The Influence of Induction Anesthetic Agents on Serum Cortisol Concentration in Morbidly Obese Patients.

• Status: Completed
• Trial end date: 2011-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The effect of etomidate administration on the adrenal cortex in obese patients is still unclear. The objective of the study was to determine the influence of single dose of etomidate on cortisol secretion in morbidly obese. The participants were divided equally into etomidate and thiopental groups, depending on kind of intravenous anesthetic used for induction of anesthesia.

Healthy patients in ASA class I and II awaiting elective abdominal laparoscopic surgery were included in the study. The participants were initially divided into two groups: the first group included patients with morbid obesity (BMI > 40), and the second group included patients with normal body weight (BMI < 25). All the patients inside the two groups were subsequently randomly and divided into etomidate and thiopental groups, according to the intravenous anesthetic used as the induction agent for general anesthesia. Finally, four groups of patients were analyzed: 1. obese, in which etomidate was used (OE group), 2. obese, in which thiopental was used (OT group), 3. patients with normal body mass, in which etomidate was used (NE group), and 4. patients with normal body mass, in which thiopental was used (NT group).

The patients excluded from the study were those who: 1. did not agree to participate, 2. were treated with steroidal drugs, 3. had cortisol metabolism disorders or were treated with drugs with a potential impact on serum cortisol concentration, 4. had a preoperative risk assessment result of ASA class III, IV and V, 5. had an initial surgical laparoscopic technique converted to laparotomy, and 6. had surgical complications increasing the level of intraoperative stress.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Military Institute of Medicine, Poland
• Treatments: Anesthetics; Cortisol succinate; Etomidate; Hydrocortisone; Hydrocortisone 17-butyrate 21-propionate; Hydrocortisone acetate; Thiopental

Criteria

Inclusion Criteria:

• healthy patients in American Society of Anesthesiologists (ASA) class I and II awaiting elective abdominal laparoscopic surgery.

Exclusion Criteria:

The patients, who

• did not agree to participate,

• were treated with steroidal drugs,

• had cortisol metabolism disorders or were treated with drugs with a potential impact on serum cortisol concentration,

• had a preoperative risk assessment result of ASA class III, IV and V,

• had an initial surgical laparoscopic technique converted to laparotomy, and

• had surgical complications increasing the level of intraoperative stress.